Drugs / Adjuvant chemotherapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT05456165 Background | May → Sep 2022 | colonic neoplasm | Gritstone bio, Inc. | Withdrawn | No outcome recorded |
| Phase 3 | NCT06520683 Background | Nov 2024 → Nov 2027 expected | colorectal cancer | Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvant chemotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05456165 ↗ |